← Open Payments lookup

ALEXIS KILBOURN: Open Payments

NPI 1952945750 · MANCELONA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$783 in 39 payments from 13 companies in 2025. Trend: 2023 $589 · 2024 $361 · 2025 $783

Food & beverage: $693Education: $90
CompanyPaymentsAmount
ABBVIE INC.13$199
Novo Nordisk Inc6$148
Astellas Pharma US Inc3$124
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$121
Axsome Therapeutics, Inc.3$48
AstraZeneca Pharmaceuticals LP2$34
Amgen Inc.1$18
Otsuka America Pharmaceutical, Inc.1$18
Aimmune Therapeutics, Inc.1$16
Exact Sciences Corporation1$15

Products named: CAPLYTA, UBRELVY, VRAYLAR, Wegovy, Auvelity, Veozah, QULIPTA, Ozempic.

Industry payments across MI — which companies pay providers there.